AAAAAA

   
Results: 1-7 |
Results: 7
Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents
Authors: Andersen, MK Christiansen, DH Kirchhoff, M Pedersen-Bjergaard, J
Citation: Mk. Andersen et al., Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents, GENE CHROM, 31(1), 2001, pp. 33-41
Mutations with loss of heterozygosity of p53 are common in therapy-relatedmyelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
Authors: Christiansen, DH Andersen, MK Pedersen-Bjergaard, J
Citation: Dh. Christiansen et al., Mutations with loss of heterozygosity of p53 are common in therapy-relatedmyelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis, J CL ONCOL, 19(5), 2001, pp. 1405-1413
Molecular cytogenetics in cancer
Authors: Pedersen-Bjergaard, J
Citation: J. Pedersen-bjergaard, Molecular cytogenetics in cancer, LANCET, 357(9255), 2001, pp. 491-492
Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on twonew cases and review of the literature since 1992
Authors: Andersen, MK Christiansen, DH Jensen, BA Ernst, P Hauge, G Pedersen-Bjergaard, J
Citation: Mk. Andersen et al., Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on twonew cases and review of the literature since 1992, BR J HAEM, 114(3), 2001, pp. 539-543
Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere
Authors: Andersen, MK Pedersen-Bjergaard, J
Citation: Mk. Andersen et J. Pedersen-bjergaard, Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere, LEUKEMIA, 14(1), 2000, pp. 105-111
Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy
Authors: Gundestrup, M Andersen, MK Sveinbjornsdottir, E Rafnsson, V Storm, HH Pedersen-Bjergaard, J
Citation: M. Gundestrup et al., Cytogenetics of myelodysplasia and acute myeloid leukaemia in aircrew and people treated with radiotherapy, LANCET, 356(9248), 2000, pp. 2158-2158
Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation
Authors: Pedersen-Bjergaard, J Andersen, MK Christiansen, DH
Citation: J. Pedersen-bjergaard et al., Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation, BLOOD, 95(11), 2000, pp. 3273-3279
Risultati: 1-7 |